APA (7th ed.) Citation

Diener, H., & Brückmann, M. (2015). Design of randomized, double-blind, evaluation in secondary stroke prevention comparing the efficacy and safety of the oral thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with embolic stroke of undetermined source (Re-Spect Esus). International journal of stroke, 10(8), . https://doi.org/10.1111/ijs.12630

Chicago Style (17th ed.) Citation

Diener, Hans-Christoph, and Martina Brückmann. "Design of Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate Vs. Acetylsalicylic Acid in Patients with Embolic Stroke of Undetermined Source (Re-Spect Esus)." International Journal of Stroke 10, no. 8 (2015). https://doi.org/10.1111/ijs.12630.

MLA (9th ed.) Citation

Diener, Hans-Christoph, and Martina Brückmann. "Design of Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate Vs. Acetylsalicylic Acid in Patients with Embolic Stroke of Undetermined Source (Re-Spect Esus)." International Journal of Stroke, vol. 10, no. 8, 2015, https://doi.org/10.1111/ijs.12630.